Abstract
There is limited head-to-head data on long-term safety and efficacy outcomes for everolimus-eluting stent (EES) and sirolimus-eluting stent (SES). In the SORT OUT (Scandinavian Organization for Randomized Trials with Clinical Outcome) IV trial we prospectively randomized 2,774 patients. The SORT
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.